KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Long-Term Investments (2017 - 2022)

Historic Long-Term Investments for Palvella Therapeutics (PVLA) over the last 5 years, with Q2 2022 value amounting to $20.3 million.

  • Palvella Therapeutics' Long-Term Investments changed N/A to $20.3 million in Q2 2022 from the same period last year, while for Jun 2022 it was $20.3 million, marking a year-over-year change of. This contributed to the annual value of $28.6 million for FY2019, which is 2832.55% down from last year.
  • According to the latest figures from Q2 2022, Palvella Therapeutics' Long-Term Investments is $20.3 million.
  • Palvella Therapeutics' Long-Term Investments' 5-year high stood at $40.0 million during Q4 2018, with a 5-year trough of $700000.0 in Q2 2018.
  • Moreover, its 4-year median value for Long-Term Investments was $24.2 million (2019), whereas its average is $21.1 million.
  • In the last 5 years, Palvella Therapeutics' Long-Term Investments soared by 392128.57% in 2019 and then tumbled by 6789.74% in 2020.
  • Over the past 4 years, Palvella Therapeutics' Long-Term Investments (Quarter) stood at $40.0 million in 2018, then decreased by 28.33% to $28.6 million in 2019, then tumbled by 68.58% to $9.0 million in 2020, then skyrocketed by 125.49% to $20.3 million in 2022.
  • Its Long-Term Investments stands at $20.3 million for Q2 2022, versus $8.9 million for Q1 2022 and $9.0 million for Q3 2020.